Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049258907> ?p ?o ?g. }
- W2049258907 endingPage "171" @default.
- W2049258907 startingPage "163" @default.
- W2049258907 abstract "Treatment with combined IL-2 and alpha-IFN has resulted in synergistic antitumour efficacy in animal studies. The mechanisms responsible for this synergy remain unclear. In this study, several immune parameters which might be involved in mediating antitumour activity have been monitored serially in 15 patients with advanced malignant melanoma or renal cell cancer during treatment with concurrent IL-2 and alpha-IFN. Both drugs were given subcutaneously in low to moderate (outpatient) dosages but for a prolonged duration. This treatment resulted in remarkable immunomodulation. In vivo induction of cytotoxicity against K562 and Daudi target cells was consistently seen, and percentages of peripheral blood cells expressing CD 25 (IL-2 receptor) and CD 56 (Leu-19) increased. In vitro proliferation of lymphocytes in response to IL-2 was enhanced during the treatment periods, whereas spontaneous proliferation was inhibited. Moreover, correlations between immune parameters and subsequent clinical responses were present in the early phase of the study. Cytotoxicity levels generated in vivo as well as the percentage of CD 56+ lymphocytes were higher in patients who responded to treatment than in non-responders. In contrast, responders had lower levels of CD 25+ cells. These findings indicate that it might be possible to select patients who are likely to benefit from prolonged immunotherapy." @default.
- W2049258907 created "2016-06-24" @default.
- W2049258907 creator A5021127401 @default.
- W2049258907 creator A5056181394 @default.
- W2049258907 creator A5082997520 @default.
- W2049258907 creator A5086174841 @default.
- W2049258907 date "1993-01-01" @default.
- W2049258907 modified "2023-10-09" @default.
- W2049258907 title "Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy" @default.
- W2049258907 cites W1485887210 @default.
- W2049258907 cites W1496465423 @default.
- W2049258907 cites W1501692141 @default.
- W2049258907 cites W1530174196 @default.
- W2049258907 cites W1535065630 @default.
- W2049258907 cites W1541086841 @default.
- W2049258907 cites W1542501019 @default.
- W2049258907 cites W1559519708 @default.
- W2049258907 cites W1567654782 @default.
- W2049258907 cites W1577005558 @default.
- W2049258907 cites W1578341569 @default.
- W2049258907 cites W1592924232 @default.
- W2049258907 cites W1753359669 @default.
- W2049258907 cites W1965107244 @default.
- W2049258907 cites W1976118287 @default.
- W2049258907 cites W1979343444 @default.
- W2049258907 cites W1980849025 @default.
- W2049258907 cites W1984445688 @default.
- W2049258907 cites W1986656701 @default.
- W2049258907 cites W1991360369 @default.
- W2049258907 cites W2017627040 @default.
- W2049258907 cites W2019134681 @default.
- W2049258907 cites W2032336406 @default.
- W2049258907 cites W2033351304 @default.
- W2049258907 cites W2036275492 @default.
- W2049258907 cites W2036899425 @default.
- W2049258907 cites W2042788727 @default.
- W2049258907 cites W2050106089 @default.
- W2049258907 cites W2053414650 @default.
- W2049258907 cites W2069147546 @default.
- W2049258907 cites W2074387411 @default.
- W2049258907 cites W2088536313 @default.
- W2049258907 cites W2099766981 @default.
- W2049258907 cites W2102016301 @default.
- W2049258907 cites W2104417744 @default.
- W2049258907 cites W2106522269 @default.
- W2049258907 cites W2107316949 @default.
- W2049258907 cites W2108162873 @default.
- W2049258907 cites W2124775275 @default.
- W2049258907 cites W2126699252 @default.
- W2049258907 cites W2130901389 @default.
- W2049258907 cites W2136445642 @default.
- W2049258907 cites W2141608710 @default.
- W2049258907 cites W2158391991 @default.
- W2049258907 cites W2160066962 @default.
- W2049258907 cites W2162588324 @default.
- W2049258907 cites W2164006518 @default.
- W2049258907 cites W2184536664 @default.
- W2049258907 cites W2253858448 @default.
- W2049258907 cites W2260574412 @default.
- W2049258907 cites W2299481294 @default.
- W2049258907 cites W2314331148 @default.
- W2049258907 cites W2405907244 @default.
- W2049258907 cites W2414566607 @default.
- W2049258907 cites W2419364244 @default.
- W2049258907 cites W4290241734 @default.
- W2049258907 cites W2105479974 @default.
- W2049258907 doi "https://doi.org/10.1038/bjc.1993.29" @default.
- W2049258907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1968230" @default.
- W2049258907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7678979" @default.
- W2049258907 hasPublicationYear "1993" @default.
- W2049258907 type Work @default.
- W2049258907 sameAs 2049258907 @default.
- W2049258907 citedByCount "23" @default.
- W2049258907 countsByYear W20492589072012 @default.
- W2049258907 crossrefType "journal-article" @default.
- W2049258907 hasAuthorship W2049258907A5021127401 @default.
- W2049258907 hasAuthorship W2049258907A5056181394 @default.
- W2049258907 hasAuthorship W2049258907A5082997520 @default.
- W2049258907 hasAuthorship W2049258907A5086174841 @default.
- W2049258907 hasBestOaLocation W20492589071 @default.
- W2049258907 hasConcept C109316439 @default.
- W2049258907 hasConcept C141071460 @default.
- W2049258907 hasConcept C150903083 @default.
- W2049258907 hasConcept C162156334 @default.
- W2049258907 hasConcept C202751555 @default.
- W2049258907 hasConcept C203014093 @default.
- W2049258907 hasConcept C207001950 @default.
- W2049258907 hasConcept C2775944032 @default.
- W2049258907 hasConcept C2776178377 @default.
- W2049258907 hasConcept C2777371288 @default.
- W2049258907 hasConcept C2777658100 @default.
- W2049258907 hasConcept C2777701055 @default.
- W2049258907 hasConcept C2778690821 @default.
- W2049258907 hasConcept C2781228144 @default.
- W2049258907 hasConcept C2909179924 @default.
- W2049258907 hasConcept C49453240 @default.
- W2049258907 hasConcept C502942594 @default.
- W2049258907 hasConcept C55493867 @default.